Wang Aili, Xu Miao, Li Li, Li Jialin
Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
Front Endocrinol (Lausanne). 2024 Dec 13;15:1467364. doi: 10.3389/fendo.2024.1467364. eCollection 2024.
Short stature, joint hyperextension, ocular hypotension, Rieger abnormalities, and delayed tooth eruption (SHORT) syndrom is a rare primary autosomal dominant genetic disorder mainly caused by pathogenic loss-of-function variants in the phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) gene. We report the case of a Chinese adult female patient with SHORT syndrome, carrying a PIK3R1 gene variant (c.1945C > T), who developed abnormal glucose metabolism and severe postprandial insulin resistance over 9 years. Although there are currently no established treatment guidelines for insulin resistance in patients with SHORT syndrome, we implemented a comprehensive treatment plan, including lifestyle interventions, metformin, and voglibose for glucose control. After 6 months of continuous observation, the patient's blood glucose levels and insulin resistance improved significantly. This case study provides useful insights for future treatment strategies.
矮小、关节过度伸展、眼压过低、里格尔异常和出牙延迟(SHORT)综合征是一种罕见的原发性常染色体显性遗传病,主要由磷酸肌醇-3-激酶调节亚基1(PIK3R1)基因的致病性功能丧失变异引起。我们报告了一例患有SHORT综合征的中国成年女性患者,携带PIK3R1基因变异(c.1945C>T),在9年多的时间里出现了葡萄糖代谢异常和严重的餐后胰岛素抵抗。尽管目前尚无针对SHORT综合征患者胰岛素抵抗的既定治疗指南,但我们实施了一项综合治疗方案,包括生活方式干预、二甲双胍和伏格列波糖以控制血糖。经过6个月的持续观察,患者的血糖水平和胰岛素抵抗显著改善。本病例研究为未来的治疗策略提供了有益的见解。